Body weight changes came from metabolic shifts rather than illness or reduced eating
The peptide instead works through a distinct mechanism involving beta-3 adrenergic receptor modulation in adipose tissue, providing fat metabolism benefits through a completely different pathway than growth hormones receptor-mediated effects
Summary The comparison between slu pp 332 and 5 amino 1mq shows two different approaches to metabolic research, each with its own advantages for scientific investigation
Heres how it helps: 1
Neelakantan and colleagues (Biochem Pharmacol, 2017) then took the pharmacological step, reporting that selective, membrane-permeable small-molecule NNMT inhibitors reversed high-fat-diet-induced obesity in mice this is the study most directly relevant to the 5-Amino-1MQ class, because it moves from the target matters to a drug against the target does something in a live animal. And again, it is a mouse study
At the enzyme level, 5-Amino-1MQ inhibits NNMTs methylation of nicotinamide reducing intracellular 1-MNA levels and diverting nicotinamide back into the NAD+ salvage pathway (via NAMPT-mediated conversion to NMN and subsequently NAD+)